Cargando…
Improved (223)Ra Therapy with Combination Epithelial Sodium Channel Blockade
[(223)Ra]RaCl(2) is the first approved α-particle–emitting therapy and is indicated for treatment of bone metastatic castration-resistant prostate cancer. Approximately half the dose is absorbed into the gastrointestinal tract within minutes of administration, limiting disease-site uptake and contri...
Autores principales: | Abou, Diane S., Fears, Amanda, Summer, Lucy, Longtine, Mark, Benabdallah, Nadia, Riddle, Ryan C., Ulmert, David, Michalski, Jeff M., Wahl, Richard L., Chesner, Denise, Doucet, Michele, Zachos, Nicholas C., Simons, Brian W., Thorek, Daniel L.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612198/ https://www.ncbi.nlm.nih.gov/pubmed/33837069 http://dx.doi.org/10.2967/jnumed.121.261977 |
Ejemplares similares
-
Cure of Disseminated Human Lymphoma with [(225)Ac]Ac-Ofatumumab in a Preclinical Model
por: Longtine, Mark S., et al.
Publicado: (2023) -
Cure of Disseminated Human Lymphoma with [(177)Lu]Lu-Ofatumumab in a Preclinical Model
por: Shim, Kyuhwan, et al.
Publicado: (2023) -
Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution
por: Peng, Lu, et al.
Publicado: (2022) -
Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis
por: Abou, Diane S., et al.
Publicado: (2015) -
Evaluation of Candidate Theranostics for (227)Th/(89)Zr Paired Radioimmunotherapy of Lymphoma
por: Abou, Diane S., et al.
Publicado: (2023)